MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing first-in-class oncology drugs, today announced that it has appointed Mihail Obrocea, M.D., as Chief Medical ...
from crm - BingNews https://ift.tt/3lCaF5D
August 04, 2021 at 05:43PM
No comments:
Post a Comment